139 related articles for article (PubMed ID: 15654835)
21. Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay.
Hayakawa S; Mori M; Okuta A; Kamegawa A; Fujiyoshi Y; Yoshiyama Y; Mitsuoka K; Ishibashi K; Sasaki S; Hattori T; Kuwabara S
J Neuroimmunol; 2008 May; 196(1-2):181-7. PubMed ID: 18462810
[TBL] [Abstract][Full Text] [Related]
22. Detection of autoantibody against carbonic anhydrase II in various liver diseases by enzyme-linked immunosorbent assay using appropriate conditions.
Hosoda H; Okawa-Takatsuji M; Tanaka A; Uwatoko S; Aotsuka S; Hasimoto N; Ozaki Y; Ikeda Y
Clin Chim Acta; 2004 Apr; 342(1-2):71-81. PubMed ID: 15026266
[TBL] [Abstract][Full Text] [Related]
23. Autoantibodies against the protease inhibitor calpastatin: a new risk factor for venous thrombosis?
Schlosser U; Lackner KJ; Scheckenhofer C; Spannagl M; Spengel FA; Hahn G; Lang B; Schmitz G
Thromb Haemost; 1997 Jan; 77(1):11-3. PubMed ID: 9031441
[TBL] [Abstract][Full Text] [Related]
24. A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16.
Mondini M; Vidali M; De Andrea M; Azzimonti B; Airò P; D'Ambrosio R; Riboldi P; Meroni PL; Albano E; Shoenfeld Y; Gariglio M; Landolfo S
Arthritis Rheum; 2006 Dec; 54(12):3939-44. PubMed ID: 17133607
[TBL] [Abstract][Full Text] [Related]
25. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
Russo K; Hoch S; Dima C; Varga J; Teodorescu M
J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
[TBL] [Abstract][Full Text] [Related]
26. [RA-related autoantibodies (anti-calpastatin, anti-gp130-RAPS, and anti-FRP antibodies)].
Tanaka M
Nihon Rinsho; 2005 Jul; 63 Suppl 7():449-52. PubMed ID: 16111298
[No Abstract] [Full Text] [Related]
27. Function blocking autoantibodies against matrix metalloproteinase-1 in patients with systemic sclerosis.
Sato S; Hayakawa I; Hasegawa M; Fujimoto M; Takehara K
J Invest Dermatol; 2003 Apr; 120(4):542-7. PubMed ID: 12648215
[TBL] [Abstract][Full Text] [Related]
28. The presence of autoantibody to recombinant lipocortin-I in patients with psoriasis and psoriatic arthritis.
Rivers JK; Podgorski MR; Goulding NJ; Wong E; McGrath JA; Flower RJ; Greaves MW
Br J Dermatol; 1990 Nov; 123(5):569-72. PubMed ID: 2147389
[TBL] [Abstract][Full Text] [Related]
29. Calpastatin levels affect calpain activation and calpain proteolytic activity in APP transgenic mouse model of Alzheimer's disease.
Vaisid T; Kosower NS; Katzav A; Chapman J; Barnoy S
Neurochem Int; 2007; 51(6-7):391-7. PubMed ID: 17513017
[TBL] [Abstract][Full Text] [Related]
30. Cleavage of the calpain inhibitor, calpastatin, during apoptosis.
Pörn-Ares MI; Samali A; Orrenius S
Cell Death Differ; 1998 Dec; 5(12):1028-33. PubMed ID: 9894609
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and characteristics of anti-56K/annexin XI autoantibodies in systemic autoimmune diseases.
Misaki Y; Van Venrooij WJ; Pruijn GJ
J Rheumatol; 1995 Jan; 22(1):97-102. PubMed ID: 7699691
[TBL] [Abstract][Full Text] [Related]
32. Heat shock protein and gliadin peptide promote development of peptidase antibodies in children with autism and patients with autoimmune disease.
Vojdani A; Bazargan M; Vojdani E; Samadi J; Nourian AA; Eghbalieh N; Cooper EL
Clin Diagn Lab Immunol; 2004 May; 11(3):515-24. PubMed ID: 15138176
[TBL] [Abstract][Full Text] [Related]
33. Interaction between catalytically inactive calpain and calpastatin. Evidence for its occurrence in stimulated cells.
Averna M; Stifanese R; De Tullio R; Defranchi E; Salamino F; Melloni E; Pontremoli S
FEBS J; 2006 Apr; 273(8):1660-8. PubMed ID: 16623703
[TBL] [Abstract][Full Text] [Related]
34. [Clinical study of autoantibody spectrum against ovarian cancer associated antigens combined with CA(125) in detecting and monitoring ovarian cancer].
Yang ZJ; Yang G; Jiang YM; Ran YL; Yang ZH; Zhang W; Zhang JQ; Pan ZM; Li L
Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):113-8. PubMed ID: 21426769
[TBL] [Abstract][Full Text] [Related]
35. [Calpain-calpastatin system in erythrocytes of children with chronic renal failure].
Polak-Jonkisz D; Purzyc L; Zwolińska D; Musiał K
Przegl Lek; 2006; 63 Suppl 3():156-8. PubMed ID: 16898518
[TBL] [Abstract][Full Text] [Related]
36. The calpain-calpastatin system and cellular proliferation and differentiation in rodent osteoblastic cells.
Murray SS; Grisanti MS; Bentley GV; Kahn AJ; Urist MR; Murray EJ
Exp Cell Res; 1997 Jun; 233(2):297-309. PubMed ID: 9194492
[TBL] [Abstract][Full Text] [Related]
37. Endogenous neutralizing anti-IL-1 alpha autoantibodies in inflammatory skin diseases: possible natural inhibitor for over expressed epidermal IL-1.
Mizutani H; Ohmoto Y; Kupper TS; Shimizu M
J Dermatol Sci; 1998 May; 20(1):63-71. PubMed ID: 10342749
[TBL] [Abstract][Full Text] [Related]
38. Immunochemical analyses of components of immune complexes in the sera of patients with autoimmune diseases.
Ferraccioli G; Karsh J; Osterland CK
J Rheumatol; 1983 Dec; 10(6):881-8. PubMed ID: 6663592
[TBL] [Abstract][Full Text] [Related]
39. Recognition of Streptococcus pyogenes and skin autoantigens in guttate psoriasis.
Villeda-Gabriel G; Santamaría-Cogollos LC; Pérez-Lorenzo R; Reyes-Maldonado E; Saúl A; Jurado-Santacruz F; Jiménez-Zamudio L; García-Latorre E
Arch Med Res; 1998; 29(2):143-8. PubMed ID: 9650329
[TBL] [Abstract][Full Text] [Related]
40. Increased levels of autoantibodies against catalase and superoxide dismutase associated with oxidative stress in patients with rheumatoid arthritis and systemic lupus erythematosus.
Mansour RB; Lassoued S; Gargouri B; El Gaïd A; Attia H; Fakhfakh F
Scand J Rheumatol; 2008; 37(2):103-8. PubMed ID: 18415766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
